Compare ERIE & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ERIE | ALGN |
|---|---|---|
| Founded | 1925 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.7B | 10.5B |
| IPO Year | 2012 | 2000 |
| Metric | ERIE | ALGN |
|---|---|---|
| Price | $271.30 | $167.74 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 16 |
| Target Price | N/A | ★ $185.79 |
| AVG Volume (30 Days) | 175.2K | ★ 1.1M |
| Earning Date | 10-29-2026 | 10-28-2026 |
| Dividend Yield | ★ 2.15% | N/A |
| EPS Growth | N/A | ★ 0.53 |
| EPS | ★ 491.00 | 4.98 |
| Revenue | ★ $1,691,774,000.00 | $387,126,000.00 |
| Revenue This Year | $2.51 | $2.24 |
| Revenue Next Year | N/A | $2.86 |
| P/E Ratio | ★ $0.55 | $34.48 |
| Revenue Growth | 5.96 | ★ 23.95 |
| 52 Week Low | $204.63 | $130.23 |
| 52 Week High | $301.61 | $200.44 |
| Indicator | ERIE | ALGN |
|---|---|---|
| Relative Strength Index (RSI) | 61.25 | 61.40 |
| Support Level | $267.40 | $164.75 |
| Resistance Level | $274.82 | $183.23 |
| Average True Range (ATR) | 8.80 | 6.43 |
| MACD | 0.63 | 1.93 |
| Stochastic Oscillator | 56.24 | 70.05 |
Erie Indemnity Co mainly performs services on behalf of the Erie Insurance Exchange relating to sales, underwriting, and issuance of policies. Erie Indemnity's results are tied to the performance of the Insurance Exchange, which principally provides automobile and homeowners insurance for individuals, along with multiperil, workers' compensation, and commercial automobile insurance for its commercial clients. The company operates exclusively in the United States.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.